Peter Olaf Hofgaard

Bilde av Peter Olaf Hofgaard
English version of this page
Telefon +47-23073027
Brukernavn
Besøksadresse Sognsvannsveien 20 Rikshospitalet 0372 OSLO
Postadresse Postboks 4950 Nydalen 0424 OSLO

Publikasjoner

  • Wang, Dong; Fløisand, Yngvar; Myklebust, Camilla Victoria; Bürgler, Simone; Ribes, Anna Maria Parente; Hofgaard, Peter Olaf; Bogen, Bjarne; Tasken, Kjetil; Tjønnfjord, Geir Erland; Schjesvold, Fredrik Hellem; Dalgaard, Jakob; Tveita, Anders & Munthe, Ludvig Andre (2017). Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice. Leukemia.  ISSN 0887-6924.  31(10), s 2114- 2121 . doi: 10.1038/leu.2017.69
  • Kikuchi, Jiro; Koyama, Daisuke; Wada, Taeko; Izumi, Tohru; Hofgaard, Peter Olaf; Bogen, Bjarne & Furukawa, Yusuke (2015). Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma. Journal of Clinical Investigation.  ISSN 0021-9738.  125(12), s 4375- 4390 . doi: 10.1172/JCI80325
  • Haabeth, Ole Audun; Tveita, Anders; Fauskanger, Marte Hotvedt; Schjesvold, Fredrik Hellem; Lorvik, Kristina Berg; Hofgaard, Peter Olaf; Omholt, Hilde; Munthe, Ludvig Andre; Dembic, Zlatko; Corthay, Alexandre & Bogen, Bjarne (2014). How do CD4+ T cells detect and eliminate tumor cells that either lack or express MHC class II molecules?. Frontiers in Immunology.  ISSN 1664-3224.  5:174 . doi: 10.3389/fimmu.2014.00174
  • Hofgaard, Peter Olaf; Jodal, Henriette Cecilie; Bommert, Kurt; Huard, Bertrand; Caers, Jo; Carlsen, Harald; Schwarzer, Rolf; Schünemann, Nicole; Jundt, Franziska; Lindeberg, Mona Mari & Bogen, Bjarne (2012). A Novel Mouse Model for Multiple Myeloma (MOPC315.BM) That Allows Noninvasive Spatiotemporal Detection of Osteolytic Disease. PLoS ONE.  ISSN 1932-6203.  7(12) . doi: 10.1371/journal.pone.0051892
  • Follin-Arbelet, Virginie; Hofgaard, Peter Olaf; Hauglin, Harald; Naderi, Soheil; Sundan, Anders; Blomhoff, Rune; Bogen, Bjarne & Blomhoff, Heidi Kiil (2011). Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model. BMC Cancer.  ISSN 1471-2407.  11 . doi: 10.1186/1471-2407-11-301 Fulltekst i vitenarkiv.
  • Corthay, Alexandre; Lundin, Katrin; Lorvik, Kristina Berg; Hofgaard, Peter Olaf & Bogen, Bjarne (2009). Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4(+) T Cells. Cancer Research.  ISSN 0008-5472.  69(14), s 5901- 5907 . doi: 10.1158/0008-5472.CAN-08-4816
  • Heier, Ingvild; Hofgaard, Peter Olaf; Brandtzæg, Per; Jahnsen, Frode Lars & Karlsson, Malin (2008). Depletion of CD4(+) CD25(+) regulatory T cells inhibits local tumour growth in a mouse model of B cell lymphoma. Clinical and Experimental Immunology.  ISSN 0009-9104.  152 . doi: 10.1111/j.1365-2249.2008.03642.x
  • Corthay, Alexandre; Skovseth, Dag Kristian; Lundin, Katrin; Røsjø, Egil; Omholt, Hilde; Hofgaard, Peter Olaf; Haraldsen, Guttorm & Bogen, Bjarne (2005). Primary antitumor immune response mediated by CD4+ T cells. Immunity.  ISSN 1074-7613.  22, s 371- 383
  • Dembic, Zlatko; Hofgaard, Peter Olaf; Omholt, Hilde & Bogen, Bjarne (2004). Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice. Scandinavian Journal of Immunology.  ISSN 0300-9475.  60, s 143- 152
  • Lundin, Katrin; Screpanti, V; Omholt, Hilde; Hofgaard, Peter Olaf; Yagita, H; Grandien, A. & Bogen, Bjarne (2004). CD4(+) T cells kill Id(+) B-lymphoma cells: FasLigand-Fas interaction is dominant in vitro but is redundant in vivo. Cancer Immunology and Immunotherapy.  ISSN 0340-7004.  53(12), s 1135- 1145
  • Dellacasagrande, Jerome; Schreurs, Olav Joseph F; Hofgaard, Peter Olaf; Omholt, Hilde; Steinsvoll, Svein E B; Schenck, Karl; Bogen, Bjarne & Dembic, Zlatko (2003). Liver metastasis of cancer facilitated by chemokine receptor CCR6. Scandinavian Journal of Immunology.  ISSN 0300-9475.  57(6), s 534- 544
  • Lundin, Knut E. A.; Hofgaard, Peter Olaf; Omholt, Hilde; Munthe, Ludvig Andre; Corthay, Alexandre & Bogen, Bjarne (2003). Therapeutic effect of anti-idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies. Blood.  ISSN 0006-4971.  102, s 605- 612
  • Lauritzsen, Grete Fossum; Hofgaard, Peter Olaf; Schenck, Karl & Bogen, Bjarne (1998). Clonal deletion as a tumor escape mechanism. International Journal of Cancer.  ISSN 0020-7136.  78, s 216- 222
  • Lauritzsen, Grete Fossum; Hofgaard, Peter Olaf; Schenck, Karl & Bogen, Bjarne (1998). Deletion of thymocytes specific for Ig idiotype produced by a tumor. International Journal of Cancer.  ISSN 0020-7136.  s 216- 222

Se alle arbeider i Cristin

  • Haabeth, Ole Audun; Tveita, Anders; Fauskanger, Marte Hotvedt; Hennig, Kjartan; Hofgaard, Peter Olaf & Bogen, Bjarne (2016). Idiotype-specific CD4+ T cells eradicate disseminated myeloma. Leukemia.  ISSN 0887-6924.  30(5), s 1216- 1220 . doi: 10.1038/leu.2015.278
  • Binsfeld, M.; Belle, L.; Hannon, M.; Hofgaard, Peter Olaf; Dubois, S; Otjacques, E.; Beguin, Y.; Bogen, B; Baron, F. & Caers, J. (2012). Adaptation of a murine chronic GvH model to study graft-versus-myeloma effect after allogeneic transplantation. Bone Marrow Transplantation.  ISSN 0268-3369.  47, s S184- S185
  • Jodal, Henriette Cecilie; Hofgaard, Peter Olaf; Dembic, Zlatko & Bogen, Bjarne (2011). A New Mouse Model for Multiple Myeloma. Scandinavian Journal of Immunology.  ISSN 0300-9475.  73(4), s 388- 388
  • Corthay, Alexandre; Lorvik, Kristina Berg; Hofgaard, Peter Olaf; Omholt, Hilde & Bogen, Bjarne (2008). Transcriptomics of a successful antitumor immune response. Scandinavian Journal of Immunology.  ISSN 0300-9475.  68, s 209- 209
  • Lorvik, Kristina Berg; Corthay, Alexandre; Lundin, Katrin; Hofgaard, Peter Olaf; Omholt, Hilde & Bogen, Bjarne (2008). Role of antigen secretion for cancer immunosurveillance. Scandinavian Journal of Immunology.  ISSN 0300-9475.  68, s 217- 218
  • Lundin, Knut E. A.; Hofgaard, Peter Olaf; Omholt, Hilde & Bogen, Bjarne (2002). MHC Class II+B lymphomas: tumor-infiltrating dendritic cells are the primary stimulators of Idiotype (Id)-specific CD4+ T cells.
  • Lundin, Knut E. A.; Hofgaard, Peter Olaf; Omholt, Hilde; Corthay, Alexandre & Bogen, Bjarne (2002). Therapeutic effect of idiotype-specific CD4+ T cells against B cell lymphoma in the absence of anti-idiotypic antibodies.
  • Lundin, Knut E. A.; Hofgaard, Peter Olaf; Omholt, Hilde & Bogen, Bjarne (2001). MHC Class II+ B lymphomas: tumor-infiltrating dendritic cells are the primary stimulators of Idiotype (Id)-specific CD4+ T cells.
  • Ellingsen, Jan Eirik & Hofgaard, Peter Olaf (1990). A comparison of protein adsorption to TiO2 and to hydroxyapatite.

Se alle arbeider i Cristin

Publisert 13. apr. 2011 11:10 - Sist endret 7. sep. 2018 16:01